Applied DNA Sciences (NASDAQ:APDN) Announces Earnings Results

Applied DNA Sciences (NASDAQ:APDN) issued its quarterly earnings results on Thursday. The technology company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.64) by $1.11, Zacks reports. The company had revenue of $0.80 million for the quarter, compared to the consensus estimate of $0.95 million. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. During the same quarter in the prior year, the business posted ($4.80) earnings per share.

Applied DNA Sciences Stock Performance

Shares of NASDAQ:APDN traded up $0.01 during trading on Friday, reaching $0.36. The stock had a trading volume of 424,759 shares, compared to its average volume of 492,432. Applied DNA Sciences has a 1-year low of $0.33 and a 1-year high of $35.90. The stock has a market cap of $354,600.00, a PE ratio of -0.02 and a beta of 0.09. The business has a fifty day moving average price of $0.44 and a 200-day moving average price of $5.39.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. StockNews.com began coverage on shares of Applied DNA Sciences in a report on Thursday. They issued a “sell” rating for the company. HC Wainwright cut their target price on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating for the company in a research note on Monday, June 10th.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.